Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Immunology|January 21, 2012
The pathway of cross-presentation is influenced by the particle size of phagocytosed antigenAlexandra Mant, Fay Chinnery, Tim Elliott, et al.
BMJ Open|November 29, 2013
Time to publication for NIHR HTA programme-funded research: a cohort studyFay Chinnery, Amanda Young, Jennie Goodman, et al.
Oncoimmunology|November 20, 2012
Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalkFay Chinnery, Catherine A King, Tim Elliott, et al.
Trials|February 4, 2018
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of diseaseFay Chinnery, Gemma Bashevoy, Amanda Blatch-Jones, et al.
BMJ Open|December 16, 2018
Evaluation of stakeholder views on peer review of NIHR applications for funding: a qualitative studySheila Turner, Abby Bull, Fay Chinnery, et al.
F1000Research|October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trialAndrew Davies, Sharon Barrans, Cathy Burton, et al.
BMJ Open|August 27, 2021
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult womenSusanne Renz, Fay Chinnery, Beth Stuart, et al.
Trials|November 1, 2025
Real world implementation of AlcoChange, a smartphone digital therapeutic to improve outcomes from alcohol-related liver disease: protocol for an individually randomised parallel group controlled trialAndrew Cook, Jonathan Bamber, Fay Chinnery, et al.
Pageof 1